Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Sabari, MD, which focused on the approval of amivantamab plus lazertinib in the first line, he looks ahead to potential uses ...

Study Links Methylmalonic Acid to Weakening of Immune Cells in Lung Cancer Oct. 31, 2024 — A new study has found a surprising link between high levels of methylmalonic acid and the weakening of ...

Getting a diagnosis of lung cancer can be scary, especially when you don't know what to expect. To help, experts will guide ...

The non-small cell lung cancer (NSCLC) drug osimertinib (Tagrisso) was associated with an increased risk of therapy-related ...

The U.S. Preventative Task Force recommends a low-dose CT scan of the chest for anyone who is between ages 50 and 80 and has ...

Lung cancer researcher, Bryant Kin, has been diagnosed with the disease despite never smoking himself in his life, he's ...

Lung cancer is killing Floridians at an alarming rate with the rate of early diagnosis too low at about 25.3%. CBS News Miami ...

Over 100 years ago, lung cancer was relatively uncommon. But this was well before Hollywood glamorized smoking and the ...

Hero Sharon tells her mother’s story and how it has spurred a passion for raising money for lung cancer research.

Lung cancer remains one of the leading causes of cancer-related deaths, but early detection and prevention can save lives.

The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...